Measuring apoptosis: Caspase inhibitors and activity assays

Cold Spring Harbor Protocols

Volumn 2014, Issue 8, 2014, Pages 799-806

  McStay, Gavin P ^a   Green, Douglas R ^b  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CALPAIN; CASPASE; CASPASE INHIBITOR; CATHEPSIN; CELL EXTRACT; CYTOCHROME C; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; GRANZYME B; INTERLEUKIN 1BETA; PROTEIN P53;

APOPTOSIS; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; NONHUMAN; OLIGOMERIZATION; PROTEIN EXPRESSION; PROTEOMICS; METABOLISM; PATHOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; STAINING;

APOPTOSIS; CASPASE INHIBITORS; CASPASES; PATHOLOGY; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING;

EID: 84922345634     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.top070359     Document Type: Article

References (59)

1. Baliga BC, Read SH, Kumar S. 2004. The biochemical mechanism of caspase-2 activation. Cell Death Differ 11: 1234-1241.
2. Benkova B, Lozanov V, Ivanov IP, Mitev V. 2009. Evaluation of recombinant caspase specificity by competitive substrates. Anal Biochem 394: 68-74.
3. Berger AB, Witte MD, Denault JB, Sadaghiani AM, Sexton KM, Salvesen GS, Bogyo M. 2006a. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Mol Cell 23: 509-521.
4. Berger AB, Sexton KB, Bogyo M. 2006b. Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity. Cell Res 16: 961-963.
5. Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM, Ricci JE, Edris WA, Sutherlin DP, Green DR, et al. 2003. A unified model for apical caspase activation. Mol Cell 11: 529-541.
6. Bossaller L, Chiang PI, Schmidt-Lauber C, Ganesan S, Kaiser WJ, Rathinam VA, Mocarski ES, Subramanian D, Green DR, Silverman N, et al. 2012. Cutting Edge: FAS (CD95) mediates noncanonical IL-1p and IL-18 maturation via caspase-8 in an RIP3-independent manner. J Immunol 189:5508-5512.
7. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, et al. 1992. Molecular cloning of the interleukin-1 beta converting enzyme. Science 256: 97-100.
8. Chai J, Wu Q, Shiozaki E, Srinivasula SM, Alnemri ES, Shi Y. 2001. Crystal structure of a procaspase-7 zymogen: Mechanisms of activation and substrate binding. Cell 107: 399-407.
9. Chauvier D, Ankri S, Charriaut-Marlangue C, Casimir R, Jacotot E. 2007. Broad-spectrum caspase inhibitors: From myth to reality? Cell Death Differ 14: 387-391.
10. Chereau D, Kodandapani L, Tomaselli KJ, Spada AP, Wu JC. 2003. Structural and functional analysis of caspase active sites. Biochemistry 42: 4151-4160.
11. Crawford ED, Seaman JE, Agard N, Hsu GW, Julien O, Mahrus S, Nguyen A Shimbo K, Yoshihara HA, Zhuang M, et al. 2012. The Degra Base: A database of proteolysis in healthy and apoptotic human cells. Mol Cell Proteomics 12: 813-824.
12. Cullen SP, Adrain C, Luthi AU, Duriez PJ, Martin SJ. 2007. Human and murine granzyme B exhibit divergent substrate preferences. J Cell Biol 176: 435-444.
13. Darmon AJ, Nicholson DW, Bleackley RC. 1995. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377: 446-448.
14. Denault JB, Bekes M, Scott FL, Sexton KM, Bogyo M, Salvesen GS. 2006. Engineered hybrid dimers: Tracking the activation pathway of caspase-7. Mot Cell 23: 523-533.
15. Edgington LE, Berger AB, Blum G, Albrow VE, Paulick MG, Lineberry N, Bogyo M. 2009. Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nat Med 15: 967-973.
16. Edgington LE, van Raam BJ, Verdoes M, Wierschem C, Salvesen GS, Bogyo M. 2012. An optimized activity-based probe for the study of caspase-6 activation. Chem Biol 19: 340-352.
17. Ekert PG, Silke J, Vaux DL. 1999. Caspase inhibitors. Cell Death Differ 6: 1081-1086.
18. Garay-Malpartida HM, Occhiucci JM, Alves J, Belizario JE. 2005. CaSPre-dictor: A new computer-based tool for caspase substrate prediction. Bioinformatics 21 Suppl 1: i169-i176.
19. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA. 1998. Inhibition of human caspases by peptide-based and macro-molecular inhibitors. J Biol Chem 273: 32608-32613.
20. Gringhuis SI, Kaptein TM, Wevers BA, Theelen B, van der Vlist M, Boekh-out T, Geijtenbeek TB. 2012. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1P via a noncanonical caspase-8 inflammasome. Nat Immunol 13: 246-254.
21. Hughes MA, Harper N, Butterworth M, Cain K, Cohen GM, MacFarlane M. Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. Mol Cell 35: 265-279.
22. Igarashi Y, Heureux E, Doctor KS, Talwar P, Gramatikova S, Gramatikoff K, Zhang Y, Blinov M, Ibragimova SS, Boyd S, et al. 2009. PMAP: Databases for analyzing proteolytic events and pathways. NucleicAcidsRes 37 (Database issue): D611-D618.
23. Kumar S. 2007. Caspase function in programmed cell death. Cell Death Differ 14: 32-43.
24. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489.
25. Luthi AU, Martin SJ. 2007. The CASBAH: A searchable database of caspase substrates. Cell Death Differ 14: 641-650.
26. Maelfait J, Vercammen E, Janssens S, Schotte P, Haegman M, Magez S, Beyaert R. 2008. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1p maturation by caspase-8. J Exp Med 205: 1967-1973.
27. Mahrus S, Trinidad JC, Barkan DT, Sali A, Burlingame AL, Wells JA. 2008. Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 134: 866-876.
28. Malladi S, Challa-Malladi M, Fearnhead HO, Bratton SB. 2009. The Apaf-1* procaspase-9 apoptosome complex functions as a proteolytic-based molecular timer. EmBO J 28: 1916-1925.
29. McStay GP, Green DR. 2014a. Detection of caspase activity using antibody-based techniques. Cold Spring Harb Protoc doi: 10.1101/pdb. prot080291.
30. McStay GP, Green DR. 2014b. Verification of a putative caspase substrate. Cold Spring Harb Protoc doi: 10.1101/pdb.prot080317.
31. McStay GP, Green DR. 2014c. Preparation ofcytosolic extract and activation of caspases by cytochrome c. Cold SpringHarb Protoc doi: 10.1101/pdb. prot080275.
32. McStay GP, Green DR. 2014d. Assaying caspase activity in vitro. Cold Spring Harb Protoc doi: 10.1101/pdb.prot080283.
33. McStay GP, Green DR. 2014e. Identification ofactive caspases usingaffinity-based probes. Cold Spring Harb Protoc doi: 10.1101/pdb.prot080309.
34. McStay GP, Salvesen GS, Green DR. 2008. Overlapping cleavage motifselec-tivity of caspases: Implications for analysis of apoptotic pathways. Cell Death Differ 15: 322-331.
35. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16: 2794-2804.
36. Oberst A, Pop C, Tremblay AG, Blais V, Denault JB, Salvesen GS, Green DR. Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation. J Biol Chem 285: 16632-16642.
37. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, Hakem R, Salvesen GS, Green DR. 2011. Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis. Nature 471: 363-367.
38. Pereira NA, Song Z. 2008. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity. Biochem Biophys Res Commun 377: 873-877.
39. Rawlings ND. Barrett AJ, Bateman A. 2012. MEROPS: The database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res 40(Database issue): D343-D350.
40. Repnik U, Stoka V, Turk V, Turk B. 2012. Lysosomes and lysosomal cathep-sins in cell death. Biochim Biophys Acta 1824: 22-33.
41. Riedl SJ, Shi Y. 2004. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mat Cell Biol 5: 897-907.
42. Riedl SJ, Fuentes-Prior P, Renatus M, Kairies N, Krapp S, Huber R, Salvesen GS, Bode W. 2001. Structural basis for the activation of human pro-caspase-7. Proc Natl Acad Sci 98: 14790-14795.
43. Rozman-Pungercar J, Kopitar-Jerala N, Bogyo M, Turk D, Vasiljeva O, Stefe I. Vandenabeele P, Bromme D, Puizdar V, Fonovic M, et al. 2003. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: When reaction mechanism is more important than specificity. Cell Death Differ 10: 881-888.
44. Scott FL, Fuchs GJ, Boyd SE, Denault JB, Hawkins CJ, Dequiedt F, Salvesen GS. 2008. Caspase-8 cleaves histone deacetylase 7 and abolishes its transcription repressor function. J Biol Chem 283: 19499-19510.
45. Shimbo K, Hsu GW, Nguyen H, Mahrus S, Trinidad JC, Burlingame AL, Wells JA. 2012. Quantitative profiling of caspase-cleaved substrates reveals different drug-induced and cell-type patterns in apoptosis. Proc Natl Acad Sci 109: 12432-12437.
46. Song J, Tan H, Shen H, Mahmood K, Boyd SE, Webb GI, Akutsu T, Whis-stock JC. 2010. Cascleave: Towards more accurate prediction ofcaspase substrate cleavage sites. Bioinformatics 26: 752-760.
47. Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA, Walczak H.2002. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducingsignallingcomplexesinaFADD-dependentmannerbut can not functionallysubstitute caspase-8. EMBO J 21: 4520-4530.
48. Stennicke HR, Renatus M, Meldal M, Salvesen GS. 2000. Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem J 350 Pt 2: 563-568.
49. Storr SJ, Carragher NO, Frame MC, Parr T, Martin SG. 2011. The calpain system and cancer. Nat Rev Cancer 11: 364-374.
50. Svingen PA, Loegering D, Rodriquez J, Meng XW, Mesner PW Jr, Holbeck S, Monks A, Krajewski S, Scudiero DA, Sausville EA, et al. 2004. Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line Panel. Clin Cancer Res 10: 6807-6820.
51. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, Ghayur T, Brady KD, Wong WW. 1997. Substrate specificities of caspase family proteases. J Biol Chem 272: 9677-9682.
52. Tewari M, Quan LT, O’Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. 1995. Yama/CPP32p, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801-809.
53. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, et al. 1992. A novel heterodimeric cysteine protease is required for interleukin-1P processing in monocytes. Nature 356: 768-774.
54. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, et al. 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 272: 17907-17911.
55. Tinel A, Tschopp J. 2004. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304: 843-846.
56. Van Damme P, Martens L, Van Damme J, Hugelier K, Staes A, Vandekerck-hove J, Gevaert K. 2005. Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis. Nat Methods 2: 771-777.
57. Van Noorden CJ. 2001. The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition. Acta Histochem 103: 241-251.
58. Vince JE, Wong WW, Gentle I, Lawlor KE, Allam R, O’Reilly L, Mason K, Gross O, Ma S, Guarda G, et al. 2012. Inhibitor ofapoptosis proteins limit RIP3 kinase-dependentinterleukin-1activation. Immunity 36:215-227.
59. Wee LJ, Tan TW, Ranganathan S. 2007. CASVM: Web-server for SVM based prediction of caspase substrates cleavage sites. Bioinformatics 23: 3241-3243.